In a Time of Universal Deceit, Telling the Truth is Revolutionary.
Saturday, October 16, 2021

F.D.A. Panel Endorses Lilly Blood Thinner

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

%d bloggers like this: